Picture of Takeda Pharmaceutical Co logo

TAK Takeda Pharmaceutical Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD





 




RNS Number : 0189V
Societe Generale SA
18 July 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical CO LTD

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

17/07/2018

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

YES: Shire PLC

 

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,378,515

0.30

7,126,829

0.91

(2) Cash-settled derivatives:

 

4,047,292

0.52

5,026

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

121,500

0.02

0

0.00

 

     TOTAL:

6,547,307

0.83

7,131,855

0.91

           

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

JPY

Ordinary

Purchase

300

4732

Ordinary

Purchase

700

4734

Ordinary

Purchase

100

4735

Ordinary

Purchase

100

4735

Ordinary

Purchase

800

4731

Ordinary

Purchase

400

4733

Ordinary

Purchase

100

4733

Ordinary

Purchase

700

4735

Ordinary

Purchase

400

4719

Ordinary

Purchase

100

4735

Ordinary

Purchase

300

4734

Ordinary

Purchase

500

4733

Ordinary

Purchase

1,300

4699

Ordinary

Purchase

100

4706

Ordinary

Purchase

100

4699

Ordinary

Purchase

2,200

4735

Ordinary

Purchase

1,700

4732

Ordinary

Purchase

100

4684

Ordinary

Purchase

400

4729

Ordinary

Purchase

700

4730

Ordinary

Purchase

100

4729

Ordinary

Purchase

600

4732

Ordinary

Purchase

1,000

4732

Ordinary

Purchase

100

4735

Ordinary

Purchase

1,300

4722

Ordinary

Purchase

500

4731

Ordinary

Purchase

100

4666

Ordinary

Purchase

100

4667

Ordinary

Purchase

700

4671

Ordinary

Purchase

1,200

4672

Ordinary

Purchase

600

4732

Ordinary

Purchase

100

4670

Ordinary

Purchase

300

4676

Ordinary

Purchase

200

4676

Ordinary

Purchase

200

4718

Ordinary

Purchase

200

4717

Ordinary

Purchase

400

4719

Ordinary

Purchase

1,300

4685

Ordinary

Purchase

3,800

4730

Ordinary

Purchase

100

4727

Ordinary

Purchase

300

4696

Ordinary

Purchase

100

4727

Ordinary

Purchase

100

4733

Ordinary

Purchase

300

4732

Ordinary

Purchase

100

4733

Ordinary

Purchase

300

4734

Ordinary

Purchase

300

4721

Ordinary

Purchase

300

4731

Ordinary

Purchase

300

4731

Ordinary

Purchase

300

4676

Ordinary

Purchase

300

4700.5

Ordinary

Purchase

200

4730.5

Ordinary

Purchase

1,000

4730

Ordinary

Purchase

1,000

4689

Ordinary

Purchase

700

4717

Ordinary

Purchase

1,000

4691

Ordinary

Purchase

100

4704

Ordinary

Purchase

100

4701

Ordinary

Purchase

300

4701

Ordinary

Purchase

200

4722

Ordinary

Purchase

900

4723

Ordinary

Purchase

100

4691

Ordinary

Purchase

900

4701

Ordinary

Purchase

500

4722

Ordinary

Purchase

1,000

4715

Ordinary

Purchase

500

4701

Ordinary

Purchase

100

4705

Ordinary

Purchase

100

4715

Ordinary

Purchase

200

4728

Ordinary

Purchase

500

4699

Ordinary

Purchase

1,000

4699

Ordinary

Purchase

900

4696

Ordinary

Purchase

700

4724

Ordinary

Purchase

800

4718

Ordinary

Purchase

1,200

4688

Ordinary

Purchase

900

4693

Ordinary

Purchase

100

4693

Ordinary

Purchase

400

4733

Ordinary

Purchase

2,000

4702

Ordinary

Purchase

300

4734

Ordinary

Purchase

500

4720

Ordinary

Purchase

300

4729

Ordinary

Purchase

600

4670

Ordinary

Purchase

100

4695

Ordinary

Purchase

200

4731

Ordinary

Purchase

100

4683

Ordinary

Purchase

100

4715

Ordinary

Purchase

1,000

4702

Ordinary

Purchase

100

4700

Ordinary

Purchase

500

4696

Ordinary

Purchase

500

4673

Ordinary

Purchase

1,000

4722

Ordinary

Purchase

200

4681

Ordinary

Purchase

1,200

4667

Ordinary

Purchase

1,000

4726

Ordinary

Purchase

900

4731

Ordinary

Purchase

400

4672

Ordinary

Purchase

100

4674

Ordinary

Purchase

2,000

4661

Ordinary

Purchase

1,000

4734

Ordinary

Purchase

200

4659

Ordinary

Purchase

1,000

4705

Ordinary

Purchase

100

4666

Ordinary

Purchase

1,000

4720

Ordinary

Purchase

400

4678

Ordinary

Purchase

800

4678

Ordinary

Purchase

1,000

4684

Ordinary

Purchase

300

4733

Ordinary

Purchase

700

4676

Ordinary

Purchase

700

4733

Ordinary

Purchase

128

4691

Ordinary

Purchase

55

4729

Ordinary

Purchase

100

4736

Ordinary

Sale

200

4729

Ordinary

Sale

200

4724

Ordinary

Sale

2,200

4730

Ordinary

Sale

1,300

4693

Ordinary

Sale

2,200

4720

Ordinary

Sale

300

4727

Ordinary

Sale

200

4692

Ordinary

Sale

1,100

4727

Ordinary

Sale

1,300

4699

Ordinary

Sale

100

4725

Ordinary

Sale

400

4730

Ordinary

Sale

300

4670

Ordinary

Sale

200

4718

Ordinary

Sale

300

4674

Ordinary

Sale

1,100

4718

Ordinary

Sale

600

4679

Ordinary

Sale

100

4741

Ordinary

Sale

400

4693

Ordinary

Sale

1,000

4671

Ordinary

Sale

200

4721

Ordinary

Sale

400

4721

Ordinary

Sale

900

4720

Ordinary

Sale

300

4673

Ordinary

Sale

400

4672

Ordinary

Sale

100

4720

Ordinary

Sale

1,600

4726

Ordinary

Sale

100

4684

Ordinary

Sale

1,300

4687

Ordinary

Sale

200

4723

Ordinary

Sale

200

4723

Ordinary

Sale

100

4724

Ordinary

Sale

100

4707

Ordinary

Sale

100

4740

Ordinary

Sale

100

4689

Ordinary

Sale

100

4725

Ordinary

Sale

100

4732

Ordinary

Sale

100

4721

Ordinary

Sale

100

4731

Ordinary

Sale

100

4733

Ordinary

Sale

100

4726

Ordinary

Sale

200

4670

Ordinary

Sale

100

4681.5

Ordinary

Sale

300

4721

Ordinary

Sale

100

4724

Ordinary

Sale

300

4679

Ordinary

Sale

2,500

4730

Ordinary

Sale

27,300

4730

Ordinary

Sale

1,000

4716

Ordinary

Sale

1,000

4733

Ordinary

Sale

1,000

4714

Ordinary

Sale

800

4720

Ordinary

Sale

1,000

4719

Ordinary

Sale

1,000

4729

Ordinary

Sale

200

4681

Ordinary

Sale

1,400

4737

Ordinary

Sale

1,000

4732

Ordinary

Sale

300

4733

Ordinary

Sale

200

4737

Ordinary

Sale

200

4680

Ordinary

Sale

800

4682

Ordinary

Sale

16,780

4719.5284

Ordinary

Sale

20,975

4719.5284

Ordinary

Sale

128

4691

Ordinary

Sale

100

4736

Ordinary

Sale

100

4736

 

Total Purchases

62,683

 

 

Total Sales

98,983

 

 

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit JPY

Ordinary

CFD

Increasing a long position

16,780

4719.5284

Ordinary

CFD

Increasing a long position

20,975

4719.5284

Ordinary

CFD

Increasing a long position

100

4724

Ordinary

CFD

Increasing a long position

100

4707

Ordinary

CFD

Increasing a long position

100

4740

Ordinary

CFD

Increasing a long position

100

4689

Ordinary

CFD

Increasing a long position

100

4725

Ordinary

CFD

Increasing a long position

100

4732

Ordinary

CFD

Increasing a long position

100

4721

 

 (c)       Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit JPY

 

 

 

 

 

 

 

 

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit JPY

 

 

 

 

 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) JPY

 

 

 

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

Date of disclosure:

18/07/2018

Contact name:

Olivier Vero

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk 

 

 

 

  

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1.         KEY INFORMATION

 

Full name of person making disclosure:

SOCIETE GENERALE SA

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Takeda Pharmaceutical CO LTD

 

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

Expiry date

JPY

e.g. American, European etc.

Ordinary

OTC put-option

Sale

15,700

4707

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,000

5075.10

European options

14/12/2018

Ordinary

OTC put-option

Sale

29,600

5073.65

European options

14/12/2018

Ordinary

OTC put-option

Sale

15,500

4491.40

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,700

4533.90

European options

14/12/2018

 

 

 

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETGGUAPMUPRURR

Recent news on Takeda Pharmaceutical Co

See all news